• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从天然产物中发现结核分枝杆菌苹果酸合酶的新型抑制剂

Discovery of novel inhibitors for malate synthase of Mycobacterium Tuberculosis from natural products.

作者信息

Wu Zhili, Wu Yuchen, Niu Yanhong, Hu Qianfang, Jiang Qihua, Liao Lingbing, Qi Guorong, Lan Haoyang, Yang Xiaolan

机构信息

Key Laboratory of Medical Laboratory Diagnostics of the Education Ministry, College of Laboratory Medicine, Chongqing Medical University, No. 1, Yixueyuan Road, Yuzhong Dist, Chongqing 400016, China.

Department of Respiratory and Critical Care Medicine, the first affiliated hospital of Chongqing Medical University, Chongqing 400016, China.

出版信息

Bioorg Med Chem Lett. 2025 Aug 1;123:130217. doi: 10.1016/j.bmcl.2025.130217. Epub 2025 Apr 3.

DOI:10.1016/j.bmcl.2025.130217
PMID:40187434
Abstract

Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) remains a global public health threat, particularly due to dormant Mtb, which necessitates prolonged drug treatment. Mycobacterium tuberculosis malate synthase (MtbMS) is a key rate-limiting enzyme in the glyoxylate shunt, essential for the survival of dormant Mtb but absent in the host. Using target-based virtual screening and biochemical approaches, we identified novel natural inhibitors of MtbMS. Molecular docking by Schrödinger and subsequent manual selection identified 11 compounds as potential inhibitors. Molecular dynamics (MD) simulations and binding-free energy analysis (MM/GBSA) demonstrated high stability and binding affinity of MtbMS with Nordihydroguaiaretic Acids (NDGA) and Meso-NDGA. NDGA and Meso-NDGA by inhibition experiment exhibited half-maximal inhibitory concentrations (IC) against MtbMS at 1.10 ± 0.01 μM and 14.29 ± 0.95 μM and by Isothermal Titration Calorimetry (ITC) showed binding constants (K) of 5.66 μM and 34.90 μM, respectively. Their minimum inhibitory concentrations (MIC) against Mtb H37Rv were 60.47 μg/mL and 30.24 μg/mL, respectively. In conclusion, natural products NDGA and Meso-NDGA are potent inhibitors of MtbMS and represent promising new scaffolds for combating dormant Mtb.

摘要

由结核分枝杆菌(Mtb)引起的结核病(TB)仍然是全球公共卫生威胁,特别是由于潜伏的Mtb,这需要长时间的药物治疗。结核分枝杆菌苹果酸合酶(MtbMS)是乙醛酸循环中的关键限速酶,对潜伏Mtb的存活至关重要,但在宿主中不存在。通过基于靶点的虚拟筛选和生化方法,我们鉴定出了MtbMS的新型天然抑制剂。使用薛定谔软件进行分子对接并随后进行人工筛选,确定了11种化合物为潜在抑制剂。分子动力学(MD)模拟和结合自由能分析(MM/GBSA)表明MtbMS与去甲二氢愈创木酸(NDGA)和内消旋-NDGA具有高稳定性和结合亲和力。通过抑制实验,NDGA和内消旋-NDGA对MtbMS的半数抑制浓度(IC)分别为1.10±0.01μM和14.29±0.95μM,通过等温滴定量热法(ITC)显示结合常数(K)分别为5.66μM和34.90μM。它们对结核分枝杆菌H37Rv的最低抑菌浓度(MIC)分别为60.47μg/mL和30.24μg/mL。总之,天然产物NDGA和内消旋-NDGA是MtbMS的有效抑制剂,是对抗潜伏Mtb的有前景的新支架。

相似文献

1
Discovery of novel inhibitors for malate synthase of Mycobacterium Tuberculosis from natural products.从天然产物中发现结核分枝杆菌苹果酸合酶的新型抑制剂
Bioorg Med Chem Lett. 2025 Aug 1;123:130217. doi: 10.1016/j.bmcl.2025.130217. Epub 2025 Apr 3.
2
Discovery of acetohydroxyacid synthase inhibitors as anti-tuberculosis lead compounds from natural products.从天然产物中发现乙酰羟酸合酶抑制剂作为抗结核先导化合物。
Bioorg Med Chem. 2025 Feb 1;118:118041. doi: 10.1016/j.bmc.2024.118041. Epub 2024 Dec 10.
3
Structure-based discovery of phenyl-diketo acids derivatives as malate synthase inhibitors.基于结构的苯二酮酸衍生物的发现作为苹果酸合酶抑制剂。
J Biomol Struct Dyn. 2021 May;39(8):2945-2958. doi: 10.1080/07391102.2020.1758787. Epub 2020 Apr 30.
4
Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.鉴定靶向结核分枝杆菌聚酮合酶 13 的抑制剂作为抗结核药物先导物。
Bioorg Chem. 2021 Sep;114:105110. doi: 10.1016/j.bioorg.2021.105110. Epub 2021 Jun 21.
5
Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.鉴定结核分枝杆菌 CtpF 作为设计新型抗结核化合物的靶标。
Bioorg Med Chem. 2020 Feb 1;28(3):115256. doi: 10.1016/j.bmc.2019.115256. Epub 2019 Dec 9.
6
Structure-guided discovery of phenyl-diketo acids as potent inhibitors of M. tuberculosis malate synthase.基于结构导向发现苯基二酮酸作为结核分枝杆菌苹果酸合酶的有效抑制剂。
Chem Biol. 2012 Dec 21;19(12):1556-67. doi: 10.1016/j.chembiol.2012.09.018.
7
Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.单链DNA适配体作为结核分枝杆菌乙酰羟酸合酶有效抑制剂的研发。
Biochim Biophys Acta. 2015 Oct;1854(10 Pt A):1338-50. doi: 10.1016/j.bbapap.2015.05.003. Epub 2015 May 16.
8
Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.抗结核化合物库筛选鉴定出新型结核分枝杆菌ATP合酶抑制剂。
Tuberculosis (Edinb). 2018 Jan;108:56-63. doi: 10.1016/j.tube.2017.10.008. Epub 2017 Oct 25.
9
A consensus reverse docking approach for identification of a competitive inhibitor of acetyltransferase enhanced intracellular survival protein from Mycobacterium tuberculosis.一种共识反向对接方法,用于鉴定结核分枝杆菌乙酰转移酶增强细胞内存活蛋白的竞争性抑制剂。
Bioorg Med Chem. 2024 Jun 15;108:117774. doi: 10.1016/j.bmc.2024.117774. Epub 2024 May 26.
10
Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.通过基于结构的虚拟筛选、抗结核活性和分子动力学模拟,鉴定新型苯甲酰胺抑制剂对结核分枝杆菌色氨酸合酶α亚基的抑制作用。
J Biomol Struct Dyn. 2019 Mar;37(4):1043-1053. doi: 10.1080/07391102.2018.1448303. Epub 2018 Mar 13.